Detalles de la búsqueda
1.
Long-term effectiveness of benralizumab in severe eosinophilic asthma patients treated for 96-weeks: data from the ANANKE study.
Respir Res
; 24(1): 135, 2023 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-37210543
2.
ChAracterization of ItaliaN severe uncontrolled Asthmatic patieNts Key features when receiving Benralizumab in a real-life setting: the observational rEtrospective ANANKE study.
Respir Res
; 23(1): 36, 2022 Feb 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-35183167
3.
Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study.
BMC Pulm Med
; 19(1): 171, 2019 Sep 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31500607
4.
Correction to: Circadian rhythm of COPD symptoms in clinically based phenotypes. Results from the STORICO Italian observational study.
BMC Pulm Med
; 19(1): 235, 2019 12 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-31801499
5.
Pharmacological approach and adherence to treatment recommendations in frequently and non-frequently exacerbating COPD patients from Italy: MISTRAL - The prospective cohort, observational study.
Pulm Pharmacol Ther
; 53: 68-77, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30193866
6.
TRITRIAL: The Impact of Fixed Triple Therapy with Beclometasone/Formoterol/Glycopyrronium on Health Status and Adherence in Chronic Obstructive Pulmonary Disease in an Italian Context of Real Life.
Int J Chron Obstruct Pulmon Dis
; 19: 475-487, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38435125
7.
Sustained Effectiveness of Benralizumab in Naïve and Biologics-Experienced Severe Eosinophilic Asthma Patients: Results from the ANANKE Study.
J Asthma Allergy
; 17: 273-290, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38562251
8.
Benralizumab in Patients With Severe Eosinophilic Asthma With and Without Chronic Rhinosinusitis With Nasal Polyps: An ANANKE Study post-hoc Analysis.
Front Allergy
; 3: 881218, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-35769575
9.
Clinical Features and Efficacy of Benralizumab in Patients with Blood Eosinophil Count Between 300 and 450 Cells/mm3: A Post Hoc Analysis from the ANANKE Study.
J Asthma Allergy
; 15: 1593-1604, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36387835
10.
Switching from one biologic to benralizumab in patients with severe eosinophilic asthma: An ANANKE study post hoc analysis.
Front Med (Lausanne)
; 9: 950883, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36117962
11.
Clinical Evolution and Quality of Life in Clinically Based COPD Chronic Bronchitic and Emphysematous Phenotypes: Results from the 1-Year Follow-Up of the STORICO Italian Observational Study.
Int J Chron Obstruct Pulmon Dis
; 16: 2133-2148, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34345170
12.
Adherence to GOLD guidelines in real-life COPD management in the Puglia region of Italy.
Int J Chron Obstruct Pulmon Dis
; 13: 2455-2462, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-30147311
13.
Clinical efficacy and tolerability of an immune-stimulant(*) constituted by inactivated bacterial bodies in the prophylaxis of infectious episodes of airways: a double blind, placebo-controlled, randomized, multicentre study.
Multidiscip Respir Med
; 9(1): 58, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25699178
14.
Health and social impacts of COPD and the problem of under-diagnosis.
Multidiscip Respir Med
; 9(1): 63, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25699180
Resultados
1 -
14
de 14
1
Próxima >
>>